Literature DB >> 28776302

Management of chikungunya arthritis.

J Kennedy Amaral Pereira1, Robert T Schoen2.   

Abstract

Chikungunya fever (CHIKF) is an emerging viral infection that has spread widely, along with its Aedes vectors, throughout the tropics and beyond, causing explosive epidemics of both acute illness and persistent disabling arthritis. There is an urgent need to mitigate the devastating impact of this illness, through vector control, personal protection, and possibly vaccine development. There is also a need to improve treatment for both acute illness and chronic arthritis. In this review, we will review the emergence of CHIK, what is known about pathogenesis and clinical manifestations, and then focus on current understanding of how to treat individual patients, in particular, those who develop chronic arthritis.

Entities:  

Keywords:  Chikungunya fever arthritis; Chikungunya virus; Chronic arthritis post-Chikungunnya; Methotrexate

Mesh:

Substances:

Year:  2017        PMID: 28776302     DOI: 10.1007/s10067-017-3766-7

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  48 in total

Review 1.  Interleukin-17 and type 17 helper T cells.

Authors:  Pierre Miossec; Thomas Korn; Vijay K Kuchroo
Journal:  N Engl J Med       Date:  2009-08-27       Impact factor: 91.245

2.  Brief Report: Management of Chronic Post-Chikungunya Rheumatic Disease: The Martinican Experience.

Authors:  Marie Blettery; Lauren Brunier; Kathleen Polomat; Florence Moinet; Christophe Deligny; Serge Arfi; Georges Jean-Baptiste; Michel De Bandt
Journal:  Arthritis Rheumatol       Date:  2016-10-09       Impact factor: 10.995

Review 3.  Chikungunya virus infections: time to act, time to treat.

Authors:  Rana Abdelnabi; Johan Neyts; Leen Delang
Journal:  Curr Opin Virol       Date:  2017-04-14       Impact factor: 7.090

4.  Rheumatic-musculoskeletal pain and disorders in a naïve group of individuals 15 months following a Chikungunya viral epidemic in south India: a population based observational study.

Authors:  A J Mathew; V Goyal; E George; D V Thekkemuriyil; B Jayakumar; A Chopra
Journal:  Int J Clin Pract       Date:  2011-12       Impact factor: 2.503

5.  Efficacy of combination DMARD therapy vs. hydroxychloroquine monotherapy in chronic persistent chikungunya arthritis: a 24-week randomized controlled open label study.

Authors:  Vinod Ravindran; George Alias
Journal:  Clin Rheumatol       Date:  2016-10-04       Impact factor: 2.980

6.  Arthritogenic alphaviral infection perturbs osteoblast function and triggers pathologic bone loss.

Authors:  Weiqiang Chen; Suan-Sin Foo; Nestor E Rulli; Adam Taylor; Kuo-Ching Sheng; Lara J Herrero; Belinda L Herring; Brett A Lidbury; Rachel W Li; Nicole C Walsh; Natalie A Sims; Paul N Smith; Suresh Mahalingam
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-14       Impact factor: 11.205

Review 7.  Chikungunya fever. Rheumatic manifestations of an emerging disease in Europe.

Authors:  M Loreto Horcada; Carlos Díaz-Calderón; Laura Garrido
Journal:  Reumatol Clin       Date:  2014-09-03

8.  Destructive arthritis in a patient with chikungunya virus infection with persistent specific IgM antibodies.

Authors:  Denis Malvy; Khaled Ezzedine; Maria Mamani-Matsuda; Brigitte Autran; Hugues Tolou; Marie-Catherine Receveur; Thierry Pistone; Jérome Rambert; Daniel Moynet; Djavad Mossalayi
Journal:  BMC Infect Dis       Date:  2009-12-10       Impact factor: 3.090

Review 9.  Molecular action of methotrexate in inflammatory diseases.

Authors:  Edwin S L Chan; Bruce N Cronstein
Journal:  Arthritis Res       Date:  2002-03-19

10.  Chronic inflammatory arthritis with persisting bony erosions in patients following chikungunya infection.

Authors:  Itta Krishna Chaaithanya; Nagarajan Muruganandam; Uppoor Raghuraj; Attayur Purushottaman Sugunan; Reesu Rajesh; Maile Anwesh; Subhodh Kumar Rai; Paluru Vijayachari
Journal:  Indian J Med Res       Date:  2014-07       Impact factor: 2.375

View more
  4 in total

1.  A Case Report of Chikungunya Fever, Rheumatoid Arthritis, and Felty's Syndrome.

Authors:  José Kennedy Amaral; Robert T Schoen
Journal:  Rheumatol Ther       Date:  2018-03-13

2.  Identification of 2-(4-(Phenylsulfonyl)piperazine-1-yl)pyrimidine Analogues as Novel Inhibitors of Chikungunya Virus.

Authors:  Julia Moesslacher; Verena Battisti; Leen Delang; Johan Neyts; Rana Abdelnabi; Gerhard Pürstinger; Ernst Urban; Thierry Langer
Journal:  ACS Med Chem Lett       Date:  2020-03-05       Impact factor: 4.345

Review 3.  Methotrexate an Old Drug with New Tricks.

Authors:  Yosra Bedoui; Xavier Guillot; Jimmy Sélambarom; Pascale Guiraud; Claude Giry; Marie Christine Jaffar-Bandjee; Stéphane Ralandison; Philippe Gasque
Journal:  Int J Mol Sci       Date:  2019-10-10       Impact factor: 5.923

Review 4.  Antivirals against the Chikungunya Virus.

Authors:  Verena Battisti; Ernst Urban; Thierry Langer
Journal:  Viruses       Date:  2021-07-05       Impact factor: 5.048

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.